Benjamin Haynor
Stock Analyst at Lake Street
(0.29)
# 4,112
Out of 4,843 analysts
10
Total ratings
22.22%
Success rate
-17.64%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PROF Profound Medical | Maintains: Buy | $17 → $11 | $5.46 | +101.65% | 1 | Apr 23, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $9.18 | +106.97% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $11.04 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $70 | $0.70 | +9,900.00% | 1 | Aug 29, 2017 | |
| SRDX Surmodics | Initiates: Buy | $44 | $29.10 | +49.48% | 1 | Jun 27, 2017 |
Profound Medical
Apr 23, 2025
Maintains: Buy
Price Target: $17 → $11
Current: $5.46
Upside: +101.65%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $9.18
Upside: +106.97%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $11.04
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $70
Current: $0.70
Upside: +9,900.00%
Surmodics
Jun 27, 2017
Initiates: Buy
Price Target: $44
Current: $29.10
Upside: +49.48%